↓ Skip to main content

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies

Overview of attention for article published in Frontiers in Pharmacology, November 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
24 news outlets
blogs
1 blog
twitter
7 X users

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
133 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Published in
Frontiers in Pharmacology, November 2021
DOI 10.3389/fphar.2021.704205
Pubmed ID
Authors

Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy, Sang-Soo Lee

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 133 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 10%
Student > Ph. D. Student 11 8%
Student > Master 9 7%
Researcher 8 6%
Lecturer 6 5%
Other 20 15%
Unknown 66 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 13%
Pharmacology, Toxicology and Pharmaceutical Science 12 9%
Medicine and Dentistry 10 8%
Chemistry 8 6%
Agricultural and Biological Sciences 4 3%
Other 13 10%
Unknown 69 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 200. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2024.
All research outputs
#194,589
of 25,225,928 outputs
Outputs from Frontiers in Pharmacology
#79
of 19,413 outputs
Outputs of similar age
#5,229
of 517,270 outputs
Outputs of similar age from Frontiers in Pharmacology
#3
of 1,070 outputs
Altmetric has tracked 25,225,928 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,413 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 517,270 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1,070 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.